REUTERS/Arnd Wiegmann Swiss pharma giant Roche is acquiring the cutting-edge biotech Spark Therapeutics for nearly $5 billion, it announced late last month. The courtship took place over 10 weeks, and was eventually sealed during a dramatic Friday in late February, according to details revealed in a new financial filing. Spark played Roche off against another, […]